Helix BioPharma (HBP) Competitors C$0.78 0.00 (0.00%) As of 04/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock HBP vs. IPA, FRX, APS, SCYB, COM, NVH, IGX, MDNA, PDP, and COVShould you be buying Helix BioPharma stock or one of its competitors? The main competitors of Helix BioPharma include ImmunoPrecise Antibodies (IPA), Fennec Pharmaceuticals (FRX), Aptose Biosciences (APS), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Medicenna Therapeutics (MDNA), Pediapharm (PDP), and Covalon Technologies (COV). These companies are all part of the "biotechnology" industry. Helix BioPharma vs. ImmunoPrecise Antibodies Fennec Pharmaceuticals Aptose Biosciences Scythian Biosciences 138267 (COM.TO) Novoheart IntelGenx Technologies Medicenna Therapeutics Pediapharm Covalon Technologies ImmunoPrecise Antibodies (CVE:IPA) and Helix BioPharma (TSE:HBP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations. Is IPA or HBP more profitable? Helix BioPharma's return on equity of 1,803.57% beat ImmunoPrecise Antibodies' return on equity.Company Net Margins Return on Equity Return on Assets ImmunoPrecise AntibodiesN/A N/A N/A Helix BioPharma N/A 1,803.57%-279.98% Which has better valuation and earnings, IPA or HBP? ImmunoPrecise Antibodies has higher revenue and earnings than Helix BioPharma. ImmunoPrecise Antibodies is trading at a lower price-to-earnings ratio than Helix BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmunoPrecise AntibodiesC$19.47M8.33-C$22.19M-C$0.89-7.30Helix BioPharmaN/AN/A-C$50.55M-C$0.95-0.82 Does the media refer more to IPA or HBP? In the previous week, ImmunoPrecise Antibodies' average media sentiment score of 0.00 equaled Helix BioPharma'saverage media sentiment score. Company Overall Sentiment ImmunoPrecise Antibodies Neutral Helix BioPharma Neutral Does the MarketBeat Community favor IPA or HBP? Helix BioPharma received 26 more outperform votes than ImmunoPrecise Antibodies when rated by MarketBeat users. Likewise, 63.46% of users gave Helix BioPharma an outperform vote while only 54.79% of users gave ImmunoPrecise Antibodies an outperform vote. CompanyUnderperformOutperformImmunoPrecise AntibodiesOutperform Votes4054.79% Underperform Votes3345.21% Helix BioPharmaOutperform Votes6663.46% Underperform Votes3836.54% SummaryImmunoPrecise Antibodies and Helix BioPharma tied by winning 4 of the 8 factors compared between the two stocks. Get Helix BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HBP vs. The Competition Export to ExcelMetricHelix BioPharmaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$41.36MC$122.22MC$5.32BC$5.54BDividend Yield1.50%3.82%5.47%6.44%P/E Ratio-0.823.0521.9429.97Price / SalesN/A4,230.36380.95584.95Price / Cash11.3213.2238.3183.35Price / Book-5.6134.746.453.54Net Income-C$50.55M-C$93.04MC$3.22BC$301.19M7 Day Performance1.30%2.19%5.85%3.59%1 Month Performance-2.50%-5.51%-9.58%-3.86%1 Year PerformanceN/A85.44%11.85%11.29% Helix BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HBPHelix BioPharmaN/AC$0.78flatN/AN/AC$41.36MN/A-0.829IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownFRXFennec PharmaceuticalsN/AC$7.02-7.4%N/A-44.8%C$135.38MC$34.86M-118.9210Gap UpAPSAptose BiosciencesN/AC$3.00-11.8%N/A-93.5%C$129.18MN/A-0.6031SCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpMDNAMedicenna TherapeuticsN/AC$0.93+9.4%N/A-32.9%C$69.58MC$4,868.39-2.5620Gap UpPDPPediapharmN/AC$0.30+1.7%N/A+0.0%C$66.36MC$11.16M-4.11N/ACOVCovalon TechnologiesN/AC$2.32+2.7%N/A+111.0%C$63.56MC$27.87M26.63N/AGap Up Related Companies and Tools Related Companies ImmunoPrecise Antibodies Competitors Fennec Pharmaceuticals Competitors Aptose Biosciences Competitors Scythian Biosciences Competitors 138267 (COM.TO) Competitors Novoheart Competitors IntelGenx Technologies Competitors Medicenna Therapeutics Competitors Pediapharm Competitors Covalon Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:HBP) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
